19 results
Acute Kidney Injury (AKI) - Differential Diagnosis Framework

PRE-Renal AKI:
 • Hypovolemia
 • Congestion
 • Medications
 •
Acute Kidney Injury ... Congestion • Medications ... Immune-mediated, Infection-mediated ... : • Urinary Retention ... #Diagnosis #nephrology
Acute Kidney Injury (AKI) - Differential Diagnosis Framework
Pre-Renal:
 • Hypovolemia, Cardiorenal, Distributive Shock, HRS, Hypercalcemia, Renal
Acute Kidney Injury ... (AKI) - Differential ... , Infection, Autoimmune ... #Acute #Kidney ... #Diagnosis #nephrology
Vancomycin Associated Acute Kidney Injury

 • Drug induced acute kidney injury is generally defined as a
Treatment includes ... prevention by minimizing ... #Vancomycin #AKI ... #pharmacology # ... diagnosis #management #nephrology
Acute Kidney Injury - Classification
Prerenal:
 • Dehydration
 • Heart failure (a.k.a. cardiorenal syndrome)
 • Liver failure
Acute Kidney Injury ... disease - Post-infectious ... prolonged prerenal AKI ... • Medications ... #diagnosis #nephrology
Causes of HyperKalemia - Differential Diagnosis
Increased extracellular K+:
 • Tissue injury
 • Hemolysis
 • Rhabdomyolysis
 •
K+: • Tissue injury ... glycosides • High acute ... Elimination: • AKI ... blockers - MCW ... Nephrology @MCW_Nephrology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
in HIV-AIDS Preventing ... 100 cells/mm3 g/mL ... Treating Acute Infection ... #Treatment #management ... #HIVAIDS #pharmacology
Hepatitis B - Treatment Indications
Treatment not indicated:
 • Immune tolerant state - HBe-Ag detectable, high HBV
Indications Treatment ... • HIV/HCV co-infection ... HBV infection with ... severe liver injury ... > 3 mg/dL) or acute
Rhabdomyolysis - Differential Diagnosis Framework and Management Summary

Causes of Rhabdomyolysis:
 • Trauma:
	- Immobilization
	- Crush injury
	- Compartment
Statins - ETOH - Infection ... declines > ALT) • AKI ... + myoglobin AKI ... urine output: 200 ml ... #nephrology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
Recommendations for Preventing ... Pre-Exposure Prevention ... Indications: ... , 2 doses (0.5 mL ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
suspension 4–6 mL ... for effective treatment ... mucosal #IDSA #Prevention ... opportunistic #infections ... #HIVAIDS #pharmacology